Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylprednisolone Preemption for aGvHD
NCT05368181Phase 2Unknown
- Sponsor
- Sichuan University
- Start
- May 2022
- Primary completion
- Jan 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of methylprednisolone in Acute Graft-Versus-Host Disease (aGvHD), sponsored by Sichuan University. Status: unknown.
02
Drugs
methylprednisolone
03
Conditions
Acute Graft-Versus-Host Disease (aGvHD)
Beyond the preview
Go deeper on NCT05368181.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05368181.